Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
View/ Open
Accepted version
Embargoed until: 5555-01-01
Reason: Version not permitted.
Embargoed until: 5555-01-01
Reason: Version not permitted.
Volume
378
Pagination
354 - 369
DOI
10.1056/NEJMoa1702417
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Issue
ISSN
0028-4793
Metadata
Show full item recordAuthors
Zeuzem, S; Foster, GR; Wang, S; Asatryan, A; Gane, E; Feld, JJ; Asselah, T; Bourliere, M; Ruane, PJ; Wedemeyer, HCollections
- Centre for Immunobiology [1121]